---
schema_version: "secwatch.filing_event.v1"
accession: "0001104659-22-042785"
form_type: "8-K"
ticker: "CTSO"
cik: "0001175151"
company_name: "Cytosorbents Corp"
filed_at: "2022-04-05T23:59:59+00:00"
generated_at: "2026-06-26T09:20:06.671511+00:00"
event_type: "leadership"
sentiment: "positive"
materiality_score: 0.55
calibrated_materiality_score: 0.55
confidence: "high"
source: SEC EDGAR
---

# CytoSorbents appoints Jiny Kim to Board of Directors as independent director

## Summary
- Appointment effective April 1, 2022; term expires at June 7, 2022 annual meeting, where she is expected to stand for re-election.
- Board expanded from five to six members; Kim brings medical device experience from Zimmer Biomet, LivaNova, and Johnson & Johnson.
- Kim currently VP at Zimmer Biomet leading Smart Implants portfolio, including launch of Persona IQ® smart knee implant.
- She will receive standard non-employee director compensation; committee assignments not yet determined.
- Company's CEO and Chairman cite her experience as valuable for U.S. expansion and potential FDA approval of DrugSorb™-ATR.

## SEC filing metadata
- accession: 0001104659-22-042785
- form_type: 8-K
- ticker: CTSO
- cik: 0001175151
- company_name: Cytosorbents Corp
- filed_at: 2022-04-05T23:59:59+00:00
- event_type: leadership
- sentiment: positive
- materiality_score: 0.55
- calibrated_materiality_score: 0.55
- confidence: high
- sec_items: 5.02, 9.01
- EDGAR index: https://www.sec.gov/Archives/edgar/data/1175151/000110465922042785/0001104659-22-042785-index.htm
- EDGAR primary document: https://www.sec.gov/Archives/edgar/data/1175151/000110465922042785/tm2210684d1_8k.htm

## Machine-readable alternates
- HTML: https://secwatch.observer/filing/0001104659-22-042785
- JSON: https://secwatch.observer/filing/0001104659-22-042785.json
- Plain text: https://secwatch.observer/filing/0001104659-22-042785.txt

## Key facts
- Executive change
  Jiny Kim was appointed as Director at Cytosorbents Corp.
  - Action: appointed
  - Role: Director
  source text: On April 1, 2022, the Board of Directors (the "Board") of CytoSorbents Corporation (the "Company") increased the size of the Board from five to six, and upon the recommendation of the Company’s Nominating and Corporate Governance Committee, appointed Ms. Jiny Kim to the Board to fill the resulting vacancy.
  evidence_url: https://www.sec.gov/Archives/edgar/data/1175151/000110465922042785/0001104659-22-042785-index.htm

This AI-assisted summary is a reading aid. Review the linked SEC EDGAR filing before relying on any specific claim.